Top Markets
#1 Black Phoenix Black Phoenix +166.14%
#2 Islamic Coin Islamic Coin +158.06%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +32.85%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +19.43%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.82%
#9 Test Test +13.54%
#10 Palladium Network Palladium Network +11.40%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
株式のランク #41547
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
株価
$0.00196068
最終同期: 2023-12-01
時価総額
$16.64K
変化（1日）
0.01%
変化（1年）
0.00%
国
FR
取引 Genomic Vision S.A. (GV)

カテゴリー

Healthcare
Genomic Vision S.A.（GV）の株価履歴
終値の最高値: $0.00 （2023-12-01）

終値の最安値: $19.42 （2014-04-01）
Genomic Vision S.A. の株価履歴（2014 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2023 -95.95%
2022 -83.21%
2021 -70.50%
2020 181.28%
2019 -14.35%
2018 -89.62%
2017 -15.12%
2016 -54.06%
2015 -24.72%
2014 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $603.20 24.43%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.22 -1.40%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $23.69 73.24%
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $572.21 -13.81%
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $314.70 99.56%
US